Research

Publications

Below you can find a list of our published research.

6152 results

Cited 15 times since 2008 (0.9 per year) source: EuropePMC

JACC. Cardiovascular imaging, Volume 1, Issue 6, 18 3 2008, Pages 729-738 Magnetic resonance cardiac vein imaging: relation to mitral valve annulus and left circumflex coronary artery. Chiribiri A, Kelle S, Köhler U, Tops LF, Schnackenburg B, Bonamini R, Bax JJ, Fleck E, Nagel E

Objectives: To evaluate in vivo anatomical relationships between the coronary sinus-great cardiac vein (CS-GCV), the mitral valve annulus (MVA), and left circumflex coronary artery (LCX) with cardiovascular magnetic resonance. Background: The CS-GCV has become an anatomical structure of interest because it provides a way of access to the heart for a number of interventional procedures. Previous reports demonstrate that the postulated close anatomical proximity of the CS-GCV to the MVA does not a... Abstract

Cited 18 times since 2008 (1.1 per year) source: EuropePMC

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Volume 11, Issue 1, 11 2 2008, Pages 31-34 Performance and survival of transvenous defibrillation leads: need for a European data registry. Goette A, Cantu F, van Erven L, Geelen P, Halimi F, Merino JL, Morgan JM, Scientific Initiative Committee of the European Heart Rhythm Association

Although the use of implantable cardioverter defibrillator (ICD) therapy has increased over the last decades, the reporting of ICD lead performance is inadequate. So far, there is neither a European nor worldwide registry on ICD leads. The published long-term results from national or multicentre registries encompass relatively small patient cohorts. Nevertheless, the failure of ICD leads may have substantial clinical consequences, including failure to sense, failure to pace, failure to defibrill... Abstract

Cited 54 times since 2008 (3.3 per year) source: EuropePMC

Diabetes care, Volume 32, Issue 2, 10 2 2008, Pages 308-310 Leptin predicts diabetes but not cardiovascular disease: results from a large prospective study in an elderly population. Welsh P, Murray HM, Buckley BM, de Craen AJ, Ford I, Jukema JW, Macfarlane PW, Packard CJ, Stott DJ, Westendorp RG, Shepherd J, Sattar N

Objective: To clarify the association of circulating levels of leptin with risk for cardiovascular disease (CVD) events and new-onset diabetes in men and women. Research design and methods: We related baseline leptin levels to CVD events (n = 864) and incident diabetes (n = 289) in an elderly population (n = 5,672) over 3.2 years of follow-up. Results: In treatment-, age-, and country-adjusted models, leptin was not associated with risk of CVD in men (hazard ratio 1.02 [95% CI 0.90-1.16] per uni... Abstract

Cited 18 times since 2008 (1.1 per year) source: EuropePMC

Biochemical and biophysical research communications, Volume 377, Issue 4, 6 1 2008, Pages 1294-1298 Apolipoprotein CI inhibits scavenger receptor BI and increases plasma HDL levels in vivo. de Haan W, Out R, Berbée JF, van der Hoogt CC, van Dijk KW, van Berkel TJ, Romijn JA, Jukema JW, Havekes LM, Rensen PC

Apolipoprotein CI (apoCI) has been suggested to influence HDL metabolism by activation of LCAT and inhibition of HL and CETP. However, the effect of apoCI on scavenger receptor BI (SR-BI)-mediated uptake of HDL-cholesteryl esters (CE), as well as the net effect of apoCI on HDL metabolism in vivo is unknown. Therefore, we evaluated the effect of apoCI on the SR-BI-mediated uptake of HDL-CE in vitro and determined the net effect of apoCI on HDL metabolism in mice. Enrichment of HDL with apoCI dose... Abstract

Cited 31 times since 2008 (1.9 per year) source: EuropePMC

European journal of nuclear medicine and molecular imaging, Volume 36, Issue 4, 5 1 2008, Pages 567-575 Prevalence and predictors of an abnormal stress myocardial perfusion study in asymptomatic patients with type 2 diabetes mellitus. Scholte AJ, Schuijf JD, Kharagjitsingh AV, Dibbets-Schneider P, Stokkel MP, van der Wall EE, Bax JJ

Purpose: The purpose of this study was to evaluate the prevalence of an abnormal stress myocardial perfusion study in a cohort of truly asymptomatic patients with type 2 diabetes mellitus using myocardial perfusion imaging by means of single photon emission computed tomography (SPECT). Secondly, we determined which clinical characteristics may predict an abnormal stress myocardial perfusion study in this population. Methods: A total of 120 asymptomatic patients (mean age 53+/-10 years) with type... Abstract

Cited 5 times since 2008 (0.3 per year) source: EuropePMC

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Volume 10 Suppl 3, 1 1 2008, Pages iii110-3 Magnetic resonance imaging and computed tomography in assessing cardiac veins and scar tissue. Van de Veire NR, Schuijf JD, Bleeker GB, Schalij MJ, Bax JJ

The success of cardiac resynchronization therapy is influenced by several issues including cardiac venous anatomy and myocardial scar tissue. This article discusses non-invasive imaging modalities that could contribute significantly to the selection process of cardiac resynchronization therapy (CRT) candidates: multi-slice computed tomography to depict the coronary sinus tributaries and magnetic resonance imaging to identify scar tissue. Abstract

Cited 13 times since 2008 (0.8 per year) source: EuropePMC

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Volume 10 Suppl 3, 1 1 2008, Pages iii48-56 Image integration in catheter ablation of atrial fibrillation. Tops LF, Schalij MJ, den Uijl DW, Abraham TP, Calkins H, Bax JJ

Over the past few years, integration of different imaging modalities to guide catheter ablation procedures for atrial fibrillation has become possible. Various strategies are nowadays available that allow integration of the anatomical information provided by fluoroscopy, computed tomography, magnetic resonance imaging, or intracardiac echocardiography with the information provided by electroanatomic mapping. This review discusses the different image integration techniques, and an overview of the... Abstract

Cited 7 times since 2008 (0.4 per year) source: EuropePMC

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Volume 4, Issue 3, 1 1 2008, Pages 318-323 Characterisation of the "vulnerable" coronary plaque by multi-detector computed tomography: a correlative study with intravascular ultrasound-derived radiofrequency analysis of plaque composition. Sarno G, Vanhoenacker P, Decramer I, Schuijf JD, Pundziute G, Margolis P, Gupta S, Bax JJ, Wijns W

Aims: To assess plaque characteristics by multi-detector computed tomography angiography in patients with known coronary artery disease and to compare these findings with those obtained with intravascular ultrasound-derived radiofrequency analysis of plaque composition. Methods and results: By computed tomography, lesions were classified on the basis of Hounsfield Units as non-calcified, calcified, or mixed. By intravascular ultrasound-derived radiofrequency analysis, plaques were classified acc... Abstract

Cited 1 times since 2008 (0.1 per year) source: EuropePMC

Ugeskrift for laeger, Volume 170, Issue 45, 1 1 2008, Pages 3637-3639 [Myocardial perfusion scintigraphy. Exact and cost-effective coronary disease imaging--secondary publication]. Hesse B, Petersen CL, Marcassa C, Bax JJ, Bengel F, Reyes E, Underwood R

Mortality rates due to coronary arterial disease (CAD) have declined as result of improved prevention, diagnosis and management, but CAD remains the leading cause of death. Myocardial perfusion scintigraphy (MPS) provides a cost-effective tool for early detection of CAD in symptomatic individuals and can stratify patients according to risk of cardiac events. MPS also provides valuable information to assist clinical decision-making. A large body of evidence supports the current applications of MP... Abstract

Cited 343 times since 2008 (20.9 per year) source: EuropePMC

Journal of the American College of Cardiology, Volume 52, Issue 22, 1 1 2008, Pages 1793-1799 Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. Rijzewijk LJ, van der Meer RW, Smit JW, Diamant M, Bax JJ, Hammer S, Romijn JA, de Roos A, Lamb HJ

Objectives: The purpose of this study was to compare myocardial triglyceride content and function between patients with uncomplicated type 2 diabetes mellitus (T2DM) and healthy subjects within the same range of age and body mass index (BMI), and to study the associations between myocardial triglyceride content and function. Background: T2DM is a major risk factor for cardiovascular disease. Increasing evidence is emerging that lipid oversupply to cardiomyocytes plays a role in the development o... Abstract

Cited 17 times since 2008 (1 per year) source: EuropePMC

Echocardiography (Mount Kisco, N.Y.), Volume 25, Issue 10, 1 1 2008, Pages 1186-1194 Left ventricular mechanical dyssynchrony as assessed by phase analysis of ECG-gated SPECT myocardial perfusion imaging. Chen J, Garcia EV, Lerakis S, Henneman MM, Bax JJ, Trimble MA, Borges-Neto S, Velazquez EJ, Iskandrian AE

Cardiac resynchronization therapy (CRT) has shown benefits in patients with severe heart failure. The traditional criteria to select patients for CRT (NYHA class III or IV, depressed left ventricular (LV) ejection fraction, and prolonged QRS duration) result in at least 30% of the selected patients with no response to CRT. Recent studies with tissue Doppler imaging (TDI) have shown that the presence of LV dyssynchrony is an important predictor for response to CRT. Phase analysis has been develop... Abstract

Cited 2 times since 2008 (0.1 per year) source: EuropePMC

The European respiratory journal, Volume 32, Issue 5, 1 1 2008, Pages 1135-1137 The secret life of steroids in asthma. Sterk PJ, Yick CY, Slats AM

Abstract

Cited 44 times since 2008 (2.7 per year) source: EuropePMC

Pacing and clinical electrophysiology : PACE, Volume 31, Issue 11, 1 1 2008, Pages 1475-1499 Noninvasive imaging in cardiac resynchronization therapy--part 1: selection of patients. Ypenburg C, Westenberg JJ, Bleeker GB, VAN de Veire N, Marsan NA, Henneman MM, van der Wall EE, Schalij MJ, Abraham TP, Barold SS, Bax JJ

Cardiac resynchronization therapy (CRT) is an established therapy for patients with advanced heart failure, depressed left ventricular function, and wide QRS complex. However, individual response varies, and a substantial amount of patients do not respond to CRT. Recent studies observed that assessment of inter- and particularly intraventricular dyssynchrony may allow identification of potential responders to CRT. In addition, presence of scar tissue and venous anatomy may play a role in the sel... Abstract

Cited 10 times since 2008 (0.6 per year) source: EuropePMC

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Volume 10 Suppl 3, 1 1 2008, Pages iii73-9 Predicting response to CRT. The value of two- and three-dimensional echocardiography. Marsan NA, Breithardt OA, Delgado V, Bertini M, Tops LF

Recently, it has been suggested that a direct assessment of left ventricular (LV) mechanical dyssynchrony may improve the selection of candidates to cardiac resynchronization therapy (CRT). In fact, when the established clinical and electrocardiographic selection criteria are applied, response to CRT may vary widely and up to one-third of the patients fail to benefit from CRT. Echocardiography has been extensively applied to assess LV dyssynchrony and to predict favourable response to CRT, using... Abstract

Cited 1 times since 2008 (0.1 per year) source: EuropePMC

Archives of internal medicine, Volume 168, Issue 21, 1 1 2008, Pages 2383 Statins and blood pressure. Trompet S, Jukema JW, Ford I, Shepherd J, Gussekloo J, Buckley BM, Westendorp RG, de Craen AJ

Abstract

Cited 16 times since 2008 (1 per year) source: EuropePMC

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Volume 10 Suppl 3, 1 1 2008, Pages iii101-5 Is nuclear imaging a viable alternative technique to assess dyssynchrony? Chen J, Bax JJ, Henneman MM, Boogers MJ, Garcia EV

Cardiac resynchronization therapy (CRT) has shown benefits in patients with end-stage heart failure (HF) (NYHA class III or IV), depressed left ventricular (LV) ejection fraction, and prolonged QRS duration (>120 ms). However, at least 30% of the patients who meet the above criteria show no response to CRT. It has shown with echocardiography that the presence of LV mechanical dyssynchrony is an important predictor for response to CRT. However, echocardiography requires expertise to produce re... Abstract

Cited 126 times since 2008 (7.7 per year) source: EuropePMC

Annals of neurology, Volume 64, Issue 5, 1 1 2008, Pages 514-522 Randomized, controlled trial of miglustat in Gaucher's disease type 3. Schiffmann R, Fitzgibbon EJ, Harris C, DeVile C, Davies EH, Abel L, van Schaik IN, Benko W, Timmons M, Ries M, Vellodi A

Objective: To evaluate the efficacy and safety of miglustat, concomitant with enzyme replacement therapy (ERT), in patients with Gaucher's disease type 3 (GD3). Methods: This 24-month, phase II, open-label clinical trial of miglustat in GD3 was conducted in two phases. During the initial 12 months, patients were randomized 2:1 to receive miglustat or "no miglustat treatment." The randomized phase was followed by an optional 12-month extension phase in which all patients received m... Abstract

Cited 84 times since 2008 (5.1 per year) source: EuropePMC

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, Volume 21, Issue 11, 1 1 2008, Pages 1244-1250 Relation between global left ventricular longitudinal strain assessed with novel automated function imaging and biplane left ventricular ejection fraction in patients with coronary artery disease. Delgado V, Mollema SA, Ypenburg C, Tops LF, van der Wall EE, Schalij MJ, Bax JJ

Objective: Automated function imaging (AFI) is a novel algorithm based on speckle-tracking imaging that can be used for assessment of global longitudinal strain of the left ventricle. The purpose of this study was to evaluate the relation between global longitudinal peak systolic strain average (GLPSS Avg) assessed by AFI and left ventricular ejection fraction (LVEF). Methods: The study population consisted of 222 consecutive patients with coronary artery disease (99 patients with acute ST-segme... Abstract

Cited 65 times since 2008 (4 per year) source: EuropePMC

European heart journal, Volume 29, Issue 22, 28 4 2008, Pages 2792-2799 CETP genotype predicts increased mortality in statin-treated men with proven cardiovascular disease: an adverse pharmacogenetic interaction. Regieli JJ, Jukema JW, Grobbee DE, Kastelein JJ, Kuivenhoven JA, Zwinderman AH, van der Graaf Y, Bots ML, Doevendans PA

Aims: Inhibition of cholesteryl ester transfer protein (CETP) increases HDL-cholesterol. However, its combination with statins may increase mortality by factors incompletely understood. We previously observed that patients with intrinsically low CETP levels (carriers of the TaqIB-B2 allele) may have less benefit from statin therapy, and here tested this pharmacogenetic hypothesis on long-term outcomes. Methods and results: We performed a 10-year follow-up analysis in 812 coronary artery disease... Abstract

Cited 39 times since 2008 (2.4 per year) source: EuropePMC

International journal of epidemiology, Volume 38, Issue 1, 24 4 2008, Pages 253-261 Adipocytokines and risk of stroke in older people: a nested case-control study. Stott DJ, Welsh P, Rumley A, Robertson M, Ford I, Sattar N, Westendorp RG, Jukema JW, Cobbe SM, Lowe GD

Background: Inflammation may play an important role in atherothrombosis and in promoting cerebral damage after stroke. We hypothesized that plasma adipocytokine concentrations would be associated with risk of stroke in older people. Methods: Nested case-control study from the Prospective Study of Pravastatin in the Elderly (PROSPER). Subjects were aged 70-82 years and followed up for a mean of 3.2 years: 266 incident stroke cases (179 confirmed as ischaemic) were compared with 532 controls match... Abstract